Purpose: Patients with epilepsy are frequently required to take antiepileptic drugs (AEDs) for a long period of time. Many studies have shown that AEDs have a negative influence on endocrine function including the thyroid gland, however the risk factors for the development of low thyroid function in these patients are unclear. This study aimed to determine the potential risk factors of low thyroid function in patients with epilepsy. Method: This was a cross-sectional study including 298 patients with epilepsy. Patients with previous thyroid disease were excluded. Epidemiologic data, type of epilepsy, etiology, the age of seizure onset, duration of epilepsy, intractable epilepsy, and number and dosage of AEDs were recorded. Levels of free thyroxine (fT4) and thyroid stimulating hormone (TSH) were measured.Results: Fifty-two of the 298 (17.4%) patients had low fT4. Older age (P = 0.004), female sex (P = 0.014), longer duration of epilepsy (P = 0.001), and intractable epilepsy (P = 0.009) were significantly associated with low fT4. Regarding individual AEDs, carbamazepine (30.1%), topiramate (28.6%), and levetiracetam (24.3%) were significantly associated with the presence of low fT4. After stepwise logistic regression of all significant variables, female sex, older age, three or more AEDs, and carbamazepine were independent risk factors for low fT4. Conclusions: Female patients with epilepsy and an older age, AED polytherapy, and carbamazepine treatment had a higher risk of low fT4. Thyroid function in these patients should be monitored closely.
Introduction
Patients with epilepsy are often required to take antiepileptic drugs (AEDs) for a long period of time. Many studies have shown that AEDs have a negative impact on the endocrine system in both pediatric and adult populations, including thyroid function, fertility, sexuality, and bone health [1] . Certain AEDs such as carbamazepine (CBZ) [2] , phenobarbital (PHB) [3] , phenytoin (PHT) [4] , valproate (VPA) [5] , and oxcarbazepine (OXC) [2, [6] [7] [8] [9] are known to affect normal thyroid function. Thyroid hormones are important for maintaining lipid and carbohydrate metabolism, cell growth and development [10, 11] . Hypothyroidism, even in subclinical form, has been associated with an increased risk of coronary heart disease [12] . The prevalence of AED-induced thyroid dysfunction and the long-term consequences remain uncertain, mainly because routine thyroid function tests are usually not performed in the clinic. Therefore, the aim of this study was to characterize the relationship between thyroid dysfunction and AEDs in unselected adult patients with epilepsy, and to identify risk factors for its development.
Methods

Study protocol approval and patient consent
The study protocol was approved by the Institutional Review Committee on Human Research of Kaohsiung Chang Gung Memorial Hospital, and written informed consent was obtained from all patients. In this cross-sectional study, we enrolled 303 patients with epilepsy aged !18 years without known thyroid disorders from the outpatient clinics of the Department of Neurology of Kaohsiung Chang Gung Memorial Hospital. Five patients were excluded from the study, including one with autoimmune thyroiditis, one with hyperthyroidism who received thyroidectomy, and three who took lithium. None of the patients took amiodarone or had a pituitary lesion in brain magnetic resonance imaging.
Clinical information was obtained by medical record review by an experienced epileptologist. A structured questionnaire was used to record demographic data, including age, sex, etiology, physical/neurological examination results, past medical history, seizure types, duration of epilepsy, current AED therapeutic state, mean seizure frequency in the past 12 months before the study, electroencephalography findings, and the results of neuroimaging studies. Clinical seizures and epileptic syndromes were defined according to the 2010 International League Against Epilepsy Classification/Organization of Seizure and Epilepsies [13] . Intractable epilepsy was defined as a failure of two adequate AEDs to achieve seizure freedom [14] , which was defined as freedom of seizures in the past 12 months before the study. The demographic data are shown in Table 1 .
Assessment of thyroid function
Chemiluminescent competitive immunoassays (ADVIA Centaur FrT4 and TSH-3 test kits; Bayer Healthcare) were performed on a Bayer ADVIA Centaur immunoassay system (Bayer Healthcare, New York City, NY) to evaluate the levels of free thyroxine (fT4) and thyroid stimulating hormone (TSH). An fT4 level between 0.89 and 1.76 ng/dL and a TSH level between 0.35 and 5.5 uIU/ml were considered normal. Low fT4 was defined as <0.89 ng/dL.
Statistical analysis
Outcome measures were defined as positivity and negativity of thyroid function according to the cutoff value. Categorical variables were compared using the chi-square test or Fisher's exact test, as appropriate, and continuous variables were assessed using the Mann-Whitney U test. Data were expressed as mean AE standard deviation (SD), and statistical significance was set at p < 0.05. Stepwise logistic regression analysis was used to identify independent factors for hypothyroidism with adjustments for other potential confounding factors. All statistical analyses were conducted using R software, version 3.2.2 [15] .
Results
Baseline characteristics of the study patients
Of the 298 enrolled patients, 155 (52.0%) were male and 143 (48.0%) were female. The mean age at entry to the study was 42.9 years (range, 19-91 years), and the mean age of seizure onset was 20.5 years (range, 0.1-77 years). With regards to the seizure type, 245 (82.2%) patients had focal seizures, 43 (14.4%) had generalized seizures, and 10 (3.4%) had seizures of undetermined type. In terms of etiology, 137 (46.0%) patients had a structural/metabolic etiology, 47 (15.8%) had a genetic etiology, and 114 (38.3%) had an unknown etiology. Moreover, 129 (43.3%) of the patients had intractable epilepsy. The mean number of AEDs used was 2.01. In terms of thyroid function tests, 52 of the 298 (17.4%) patients had low fT4, of whom three had a high TSH level and received thyroxine replacement therapy.
Associations of low fT4 with clinical factors and AED use
Comparing the patients with low fT4 to those with normal fT4, low fT4 was significantly associated with an older age (47.1 versus 41.9 years, P = 0.004), female sex (63.5% versus 44.7%, P = 0.014), longer duration of epilepsy (28.1 versus 21.2 years, P = 0.001), and intractable epilepsy (59.6% versus 39.8%, P = 0.009) ( Table 2 ). There were no significant associations between individual types of seizure, etiology, and seizure frequency with the development of low fT4. In addition, there was no significant difference in TSH level between the patients with and without intractable epilepsy (2.85 versus 1.63 uIU/ml, P = 0.084).
A higher number of AEDs was significantly associated with low fT4. The rates of low fT4 were 5.2%, 14.5%, and 34.5% in the patients taking one, two, and three or more AEDs, respectively. Regarding individual AEDs, CBZ (30.9%), topiramate (TPM) (30.6%), and levetiracetam (LEV) (25.7%) were significantly associated with the presence of low fT4 (Table 3) .
Stepwise logistic regression of all significant variables in logistic regression analysis revealed that female sex (P = 0.003, OR = 2.868, 95% CI = 1.426-5.771), age (P = 0.036, OR = 1.032, 95% CI = 1.002-1.062), three or more AEDs (P = 0.08, OR = 6.346, 95% CI = 1.629-24.717), and CBZ (P = 0.002, OR = 3.152, 95% CI = 1.545-6.431) were independent risk factors for low fT4.
Discussion
In this study, 17.4% of our unselected adult patients with epilepsy who were taking AEDs had a low level of fT4. This is consistent with previous studies which reported rates ranging from 12.7% to 35.9% [2, 9, 16] . We identified several clinical risk factors for the development of a low thyroid hormone level in our patients, including female sex, old age and AED polytherapy, especially CBZ. Abbreviations;: n, number of cases; SD, standard deviation; AED, antiepileptic drug.
In the general population, older age females are known to be more likely to develop hypothyroidism [17] . In this study, the patients with low fT4 were more commonly female and had an older age, which is likely representative of the background risk. In addition to these patients are at a higher risk of low fT4 when exposed to AEDs, suggesting that clinicians should regularly monitor thyroid function when treating elderly female patients with epilepsy.
We found that the patients with a longer duration of epilepsy had a higher risk of low fT4. There are several possible explanations for this association, including more seizure activity and/or longer duration of AED exposure. Patients with a longer duration of epilepsy are more likely to have a higher seizure burden, which may have a negative impact on thyroid hormone hemostasis, especially through the hypothalamus and TSH. However, we did not find an association between recent seizure frequency and low fT4. Furthermore, the level of TSH was not lower in the patients with intractable epilepsy. Another possibility is that patients with a longer duration of epilepsy are more likely to be exposed to a longer duration of AED treatment. In this study, the associations between intractable epilepsy and a longer duration of epilepsy were significantly associated with low fT4 rather than recent seizure frequency. This suggests that AEDs play a more important role in causing low fT4 than seizures. This is further supported by the strong association between the number of AEDs and the development of low fT4 in this study.
Among all AEDs, CBZ remained significantly associated with low fT4 after stepwise logistic regression analysis. Several AEDs, especially enzyme-inducing AEDs, have been reported to have adverse effects on thyroid hormone homeostasis including CBZ [2] , PHB [3] , PHT [4] , VPA [18] , and OXC [2, [6] [7] [8] [9] . The International League Against Epilepsy recommends CBZ as first-line treatment for adult patients with focal seizures, generalized onset tonicclonic seizures, and especially in elderly adults with focal seizures [19] . Nearly one third (30.9%) of our patients who took CBZ had a serum fT4 level below the reference range, which is consistent with earlier reports that reported a low fT4 level in 12.5% and 32.4% of CBZ-treated male and female patients with epilepsy, respectively [8, [20] [21] [22] [23] . The strength of our study is that we included unselected patients with epilepsy and hitherto the largest cohort on this subject. Several mechanisms for AED-induced abnormal thyroid function have been postulated, including competitive binding of thyroid hormone to thyroxine-binding globulin [24] [25] [26] , increased peripheral conversion of T4 to active T3 [27] , and interference with the hypothalamic-pituitary axis [24, 28, 29] . The adverse impact of AEDs on the hepatic P-450 enzyme system may be due to accelerated clearance of thyroid hormone [30, 31] . A previous prospective study also reported that alterations in thyroid function were reversible after the withdrawal of CBZ [32] .
In conclusion, the presence of low fT4 was common in our patients with epilepsy who were receiving AEDs therapy, and this was associated with different clinical factors. Of the AEDs, CBZ was most commonly associated with a low thyroid hormone level. Both female and male patients were at risk, however the female patients had a more significant risk. Old age and AED polytherapy also increased the risk of low fT4. Regularly monitoring thyroid function may be required for patients with epilepsy with highrisk factors, such as old age, female sex, and multiple AED therapy, especially CBZ.
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